Completed

Phase 3
Age: 35Years +
All Genders
ID00000144

Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)

Led by National Eye Institute (NEI) · Updated on 2006-06-05

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

To compare the safety and long-term efficacy of argon laser treatment of the trabecular meshwork with standard medical treatment for primary open-angle glaucoma.

CONDITIONS

Brief Title

Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)

Who Can Participate

Age: 35Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

At the time of recruitment, patients had to be at least 35 years old with an intraocular pressure of at least 22 mm Hg or greater in each eye and evidence of optic nerve damage in at least one eye.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

RANDOMIZED

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Similar Trials

Bioequivalence Study Comparing Generic Bimatoprost Ophthalmi...

Open-angle Glaucoma

Actively Recruiting

4 locations

Additive Benefits of Semaglutide for Open-AngLe Glaucoma - a...

Primary Open Angle Glaucoma (POAG)

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial